Characterization of Leishmania donovani antigens encapsulated in liposomes that induce protective immunity in BALB/c mice - Wikidata - awgldk - TriplyDB

Characterization of Leishmania donovani antigens encapsulated in liposomes that induce protective immunity in BALB/c mice

Characterization of Leishmania donovani antigens encapsulated in liposomes that induce protective immunity in BALB/c mice

http://www.wikidata.org/entity/Q39672345

about

Possibilities and challenges for developing a successful vaccine for leishmaniasis Potentiating effects of MPL on DSPC bearing cationic liposomes promote recombinant GP63 vaccine efficacy: high immunogenicity and protection Liposomes as nanomedical devices Therapy with sodium stibogluconate in stearylamine-bearing liposomes confers cure against SSG-resistant Leishmania donovani in BALB/c mice Leishmania donovani: immunostimulatory cellular responses of membrane and soluble protein fractions of splenic amastigotes in cured patient and hamsters Leishmania donovani triose phosphate isomerase: a potential vaccine target against visceral leishmaniasis Immunogenicity and efficacy of single antigen Gp63, polytope and polytopeHSP70 DNA vaccines against visceral Leishmaniasis in experimental mouse model Evaluation of Leishmania donovani protein disulfide isomerase as a potential immunogenic protein/vaccine candidate against visceral Leishmaniasis Identification of novel Leishmania donovani antigens that help define correlates of vaccine-mediated protection in visceral leishmaniasis Visceral Leishmaniasis: Advancements in Vaccine Development via Classical and Molecular Approaches Th1 stimulatory proteins of Leishmania donovani: comparative cellular and protective responses of rTriose phosphate isomerase, rProtein disulfide isomerase and rElongation factor-2 in combination with rHSP70 against visceral leishmaniasis.Isolation, characterization and antimicrobial evaluation of a novel compound N-octacosan 7β ol, from Fumaria parviflora Lam.Negatively charged liposomes show potent adjuvant activity when simply admixed with protein antigens Apoptosis mediated leishmanicidal activity of Azadirachta indica bioactive fractions is accompanied by Th1 immunostimulatory potential and therapeutic cure in vivo Characterization of immunoglobulin G and its subclass response to Indian kala-azar infection before and after chemotherapy.Comparison of in vivo Adjuvanticity of Liposomal PO CpG ODN with Liposomal PS CpG ODN: Soluble Leishmania Antigens as a Model.β-Nitrostyrenes as Potential Anti-leishmanial Agents.Sphingomyelin Liposomes Containing Soluble Leishmania major antigens Induced Strong Th2 Immune Response in BALB/c Mice Leishmaniasis: focus on the design of nanoparticulate vaccine delivery systems.Vaccine Development Against Leishmania donovani.Cationic liposomal vaccine adjuvants in animal challenge models: overview and current clinical status.Recent progress towards development of a Shigella vaccine.Delivery systems for Leishmania vaccine development.Proteoliposomes in nanobiotechnology.Immunological consequences of stress-related proteins--cytosolic tryparedoxin peroxidase and chaperonin TCP20--identified in splenic amastigotes of Leishmania donovani as Th1 stimulatory, in experimental visceral leishmaniasis.Nanobiotechnologic approach to a promising vaccine prototype for immunisation against leishmaniasis: a fast and effective method to incorporate GPI-anchored proteins of Leishmania amazonensis into liposomes.gp63 in stable cationic liposomes confers sustained vaccine immunity to susceptible BALB/c mice infected with Leishmania donovani.Combination therapy with paromomycin-associated stearylamine-bearing liposomes cures experimental visceral leishmaniasis through Th1-biased immunomodulation Liposomal formulations in the pharmacological treatment of leishmaniasis: a review.In vitro responses of human peripheral blood mononuclear cells to whole-cell, particulate and soluble extracts of Leishmania promastigotes.Biodistribution of liposome/DNA systems after subcutaneous and intraperitoneal inoculation.Identification of Potential MHC Class-II-Restricted Epitopes Derived from Leishmania donovani Antigens by Reverse Vaccinology and Evaluation of Their CD4+ T-Cell Responsiveness against Visceral Leishmaniasis.Leishmaniasis in humans: drug or vaccine therapy?PEGylation of cationic liposomes encapsulating soluble Leishmania antigens reduces the adjuvant efficacy of liposomes in murine model.Dermotropic Leishmania donovani in Sri Lanka: visceralizing potential in clinical and preclinical studies.Liposomal Elongation Factor-1α Triggers Effector CD4 and CD8 T Cells for Induction of Long-Lasting Protective Immunity against Visceral Leishmaniasis.Evaluation of an ELISA for canine leishmaniasis immunodiagnostic using recombinant proteins.Searching Genes Encoding Leishmania Antigens for Diagnosis and Protection The potential HLA Class I-restricted epitopes derived from LeIF and TSA of Leishmania donovani evoke anti-leishmania CD8+ T lymphocyte response

P2860

Q26749758-F556AA70-5C1A-4855-949F-22B04C0DFF57 Q27305883-7EEB0662-13FD-4885-BD48-B33DA3C6F1A1 Q28088315-CA0A7772-3A73-4A26-BFBC-A03A588EAA61 Q28477398-B5B880FB-5152-408C-8949-A31A5C6553A7 Q28480398-0B129BBD-DA1D-409C-B270-9C411035F036 Q28483976-5A0BD90B-B985-4FF3-8D0B-79F6BD22BC9B Q30940594-53D3748B-A0E6-431D-AC44-A23329D0A814 Q31060208-C0C950D8-6C4D-4B21-8952-337E9B21ACDB Q33463435-D328CA8C-4716-489A-9A39-1A698C769F1D Q34076804-BB2EE1E1-7F96-446D-BDA3-3BC8E019E0E8 Q34277331-1230AF91-65CA-4539-9427-67A58538E1C9 Q35118485-F981BB08-4BD5-4D33-9305-7C8D16331AAF Q35141341-040C7F1F-84BF-41DB-8C92-F09141B3C96D Q35238066-2430B6E1-C0AC-4D5A-A6A6-2438FAE641C3 Q35548955-1A4625E4-A698-4B51-AE3D-F14FFDC96103 Q36652638-CD4B4DD6-F3D7-41E9-9F68-89DCD43094BF Q37224367-25F953DD-A83A-4971-880A-1DB58A5BD9FD Q37246219-E48BDA02-930C-4B09-809B-021B9D6EECEB Q37965724-C0062F7A-3134-4729-A727-A7CC85777B31 Q38012112-98548DF0-C4D1-416A-9E14-8D14A9310B76 Q38028994-143B0001-854F-4D2D-A232-1B8CA80DBD9D Q38068954-07A90701-115B-4EC4-BFE1-E7E1601B2C2E Q38746362-C9B1188C-F400-49F1-B541-022028E24F99 Q39310225-F8BCA1AB-6383-46D7-A7F2-F19CC8C5CE4A Q41603970-F11C80D6-6A6C-4771-9889-72537BACC6AB Q41723457-5C8AE082-CFC9-437C-816B-67E4EE1FA412 Q42002483-FC5CC2FE-D4C4-4BC8-A2AC-7C451758C1E3 Q42706310-7B146EC6-36B5-4CFC-8FFE-847BA538EDD5 Q43168913-7044A774-8EE6-4B6D-99D9-CD1C5B38542F Q45080997-7665F979-1BAF-4A6E-9429-10BE08461B3D Q45889122-4F7E2671-162F-4229-AE4A-8016A0411E3E Q47201994-113AED53-0292-4924-90E1-3A56C1979DAB Q47556262-3CB63FC2-F447-4F15-B1E2-B930AACC57CB Q48332907-D7D327F7-5E1B-4722-8E68-2A62F77A1D41 Q48347654-527028D5-7B54-410C-9ABF-81ED2C3062B3 Q49210114-ECC34AD4-E171-4DA7-90BB-28A65F612C26 Q52616476-6CD4EA77-2927-4E5D-A326-AC750A59D4CD Q58647150-3AEB0A99-E187-40F8-AA76-CA9F360F53DE Q58705894-20E77654-2D07-4E7F-978D-231BBB58C0DA

P2860

Characterization of Leishmania donovani antigens encapsulated in liposomes that induce protective immunity in BALB/c mice

http://www.wikidata.org/entity/Q39672345

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

2002年论文

@zh

2002年论文

@zh-cn

name

Characterization of Leishmania ...... ective immunity in BALB/c mice

@en

Characterization of Leishmania ...... ctive immunity in BALB/c mice.

@nl

type

label

Characterization of Leishmania ...... ective immunity in BALB/c mice

@en

Characterization of Leishmania ...... ctive immunity in BALB/c mice.

@nl

prefLabel

Characterization of Leishmania ...... ective immunity in BALB/c mice

@en

Characterization of Leishmania ...... ctive immunity in BALB/c mice.

@nl

P1433

Q39672345-3CF002E7-408E-499A-918C-D0A9FF5EE8A1

P1476

Q39672345-B7D12E71-6B10-49C7-B61D-E182B556386F

P2093

Q39672345-45BA1FEA-6E21-49ED-8D54-211CD566F2A5

Q39672345-4F5AA03E-ECC9-4D32-B36F-115A9BCE6496

Q39672345-5531EC81-A88A-4C79-B8DA-D314644FF185

Q39672345-A6CEFD98-5A86-4FC6-BDB0-A922BFABAE55

Q39672345-C5DE96C5-DA80-401C-8282-1D9A9FBC20E2

Q39672345-DC643967-60E2-4F16-AFA2-93507E0730E0

P2860

Q39672345-0C314F72-5263-468F-834B-9BE3D7AA1583

Q39672345-0E538D88-754B-4E2A-AC92-68BA13947A91

Q39672345-142FD23F-5177-4273-8351-E9829CEA73E8

Q39672345-1F0C7283-C4F9-42BA-8301-E039CB4E0918

Q39672345-1F2A51F6-6916-435A-9101-5F0920585E49

Q39672345-2172AE1A-AE46-416A-9532-C93EB1620C1D

Q39672345-27B8026C-1820-436D-8039-C31C0A8DC9E6

Q39672345-2856330A-3CDD-4710-B4B0-D9909CAB5699

Q39672345-28638558-A053-48CA-B848-FF6EC95EAF8A

Q39672345-357F9A14-746E-4EBB-B183-B6582D25979F

P304

Q39672345-F0E1476E-CDCB-42CC-9447-A5DE738F2487

P31

Q39672345-B6292EAC-480F-4FAF-BF24-06C6AA39795F

P356

Q39672345-F0976020-24DC-44D2-B0D3-60DA403B7F1C

P407

Q39672345-AD58B1F1-73FE-4297-9F1B-8C7F08EC7C3C

P433

Q39672345-80339E85-A186-4FA2-B39A-3223B03F4E09

P478

Q39672345-402EFB95-85B4-4818-BEF2-5AF8A3C61ADC

P577

Q39672345-C5C6ADD1-6728-4BF1-9DEA-535BDDD31DE3

P5875

Q39672345-0BFE3E7E-8AA2-4A3D-AF03-ED8448DC3F61

P698

Q39672345-AF0F92AD-F5B3-42B3-B7F4-EEACD4FC3CFE

P932

Q39672345-834085F9-DF8E-4821-AB8D-A65FF01AF725

P356

IAI.70.12.6697-6706.2002

P1433

Infection and Immunity

P1476

Characterization of Leishmania ...... ective immunity in BALB/c mice

@en

P2093

Farhat Afrin

http://www.w3.org/2001/XMLSchema#string

Khairul Anam

http://www.w3.org/2001/XMLSchema#string

Meenakshisundram Gopinath

http://www.w3.org/2001/XMLSchema#string

Nahid Ali

http://www.w3.org/2001/XMLSchema#string

Ravindran Rajesh

http://www.w3.org/2001/XMLSchema#string

Swati Pal

http://www.w3.org/2001/XMLSchema#string

P2860

Protein measurement with the Folin phenol reagent

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications

In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma

Cleavage of structural proteins during the assembly of the head of bacteriophage T4

Synthetic peptide-based enzyme-linked immunosorbent assay for serodiagnosis of visceral leishmaniasis

Silver staining of proteins in polyacrylamide gels

Functional diversity of helper T lymphocytes

A recombinant Leishmania chagasi antigen that stimulates cellular immune responses in infected mice.

An avirulent lipophosphoglycan-deficient Leishmania major clone induces CD4+ T cells which protect susceptible BALB/c mice against infection with virulent L. major

Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis

P304

6697-6706

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/IAI.70.12.6697-6706.2002

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

70

http://www.w3.org/2001/XMLSchema#string

P577

2002-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11030264

http://www.w3.org/2001/XMLSchema#string

P698

12438344

http://www.w3.org/2001/XMLSchema#string

P932

133102

http://www.w3.org/2001/XMLSchema#string